Demand for Prophylaxis after Bioterrorism-Related Anthrax Cases, 2001
Published Date:Jan 2005
Source:Emerg Infect Dis. 11(1):42-47.
Health Care Surveys
Patient Acceptance Of Health Care
Physician's Practice Patterns
Primary Health Care
Research, Anthrax, Fluoroquinolone, Prophylaxis
Funding:U50/CCU 515878/CC/ODCDC CDC HHS/United States
Description:Media reports suggested increased public demand for anthrax prophylaxis after the intentional anthrax cases in 2001, but the magnitude of anthrax-related prescribing in unaffected regions was not assessed. We surveyed a random sample of 400 primary care clinicians in Minnesota and Wisconsin to assess requests for and provision of anthrax-related antimicrobial agents. The survey was returned by 239 (60%) of clinicians, including 210 in outpatient practice. Fifty-eight (28%) of those in outpatient practice received requests for anthrax-related antimicrobial agents, and 9 (4%) dispensed them. Outpatient fluoroquinolone use in both states was also analyzed with regression models to compare predicted and actual use in October and November 2001. Fluoroquinolone use as a proportion of total antimicrobial use was not elevated, and anthrax concerns accounted for an estimated 0.3% of all fluoroquinolone prescriptions. Most physicians in Minnesota and Wisconsin managed anthrax-related requests without dispensing antimicrobial agents.
image/gif image/jpeg image/gif image/jpeg image/gif image/jpeg text/plain text/plain
You May Also Like: